POSCO International's pharmaceutical business in Sudan is generating profits while at the same time contributing to improving people's health in the African country.General Medicines Co. (GMC) in Sudan, a joint venture between POSCO International and Shinpoong Pharmaceutical, posted operatin
The Ministry of Economy and Finance announced on Dec. 26 that the enforcement decree of the Income Tax Act has been revised.At present, a stock transfer income tax is imposed, even if a person’s stock is less than one billion won, if the stock added to the sum of those of his or her spouse and linea
As we approach another new year with COVID-19 in tow, the pandemic still weighs on businesses and organizations of all sizes. The last three years have been a reminder of the need for agility and resilience in business leadership along with a willingness to engage on a global scale. These attributes
Prime Minister Han Deok-soo said on Dec. 8 that the government will issue work resumption orders to the striking cargo transport workers in the petrochemical and steel sectors on the day.Presiding over a temporary cabinet meeting, Han said, "Today, the second return-to-work order will be issued to c
Pernod Ricard Korea has released the new high-end collection of the prestige whisky ‘Royal Salute’, ‘Royal Salute 30 Year Old (Royal Salute 30YO – Key to the Kingdom)’.Royal Salute has been leading the innovation of Scotch whiskey based on the know-how accumulated over many years, presenting the lin
EOFlow Co. announced on Oct. 25 that it has received certification from the Ministry of Health of Indonesia to commercialize its wearable insulin pump ‘EOPatch’ and its controller ‘ADM’. Its smartphone app ‘Narsha’ does not require an approval from the ministry.On December 2021, EOFlow announced tha
EOFlow Co., the producer of EOPatch, a small and light wearable insulin pump, has exported an EOPatch production line to its joint venture in China, Sinoflow Co., the company announced on Oct. 17.On Sept. 30, the company shipped equipment to set up an EOPatch production line in Sinoflow, along with
EOFlow Co., a provider of wearable drug delivery solutions, announced on Sept. 23 that its European exclusive distributing partner A. Menarini Diagnostics showcased its tubeless, wearable, and disposable insulin pump “EOPatch” at the annual meeting of the European Association for the Study of Diabet
EOFlow Co., a provider of wearable drug delivery solutions, announced on Aug. 12 that its European partner, A. Menarini Diagnostics (‘Menarini’) will officially launch its tubeless, wearable, and disposable insulin pump “EOPatch” in Europe on Sept. 1, 2022.EOPatch is one of the only two fully dispos
The U.S. Food and Drug Administration (FDA) will make a decision on awarding marketing approval for Rolontis, the first new biotech drug candidate of Hanmi Pharmaceutical, in September. According to the FDA’s Prescription Drug User Fee Act (PDUFA), Rolontis’ approval deadline is set at Sept. 9.The F
The author is an analyst of NH Investment & Securities. He can be reached at pk.park@nhqv.co. -- Ed. ctDNA technology a game changerAt this year’s ASCO conference, circulating tumor DNA (ctDNA) was at the center of attention. Though various technological challenges need to be tackled first for full-
EOFlow Co. announced on May 20 that the first patient has been enrolled in the pivotal study of two-part wearable artificial pancreas “EOPatch X” on people with type 1 diabetes in Korea.According to the company, the first EOPatch X patient was enrolled by Dr. Kim Jae-hyeon of the Department of Endoc
The Institute for Basic Science (IBS) has developed a porous gold nanoelectrode-based biosensor for immediate disease diagnosis based on blood and urine. The institute succeeded in diagnosing prostate cancer with the biosensor that covers infectious diseases as well as cancers.A urine or blood biosa
EOFlow Co., a provider of wearable drug delivery solutions, has officially launched an iOS version of ‘Narsha,’ a smartphone application for wearable insulin pump in Korea.It has been nine months since the company officially launched the Android application of Narsha. Narsha is the world’s first sma
Hanmi Pharmaceutical's innovative new drug for acute myeloid leukemia (AML) has won a Fast Track designation from the U.S. FDA. The new drug, HM43239, was licensed out to Aptose, a U.S. biotech company listed on the NASDAQ, in November 2021.“The FDA’s Fast Track designation is a recognition of t
KT announced on April 13 that it has signed a business agreement with Hanoi Medical University to launch a pilot telemedicine service for chronically ill patients.KT will start verifying the feasibility of telemedicine services for patients with chronic diseases together with Hanoi Medical Universit
Samsung Electronics’ Galaxy Watch has narrowed its market share gap with Apple Watch. Samsung changed the operating system of Galaxy Watch to the Wear OS in cooperation with Google, and this appears to have paid off.Counterpoint Research, a market research firm, announced on March 15 that the smartw
The Korea Institute of Science and Technology (KIST) announced on March 6 that its research team led by Dr. Lee Su-yeon has developed a low-power consumption and high-efficiency artificial sensory neuron device, which is expected to facilitate the commercialization of in-sensor computing imitating t
MedPacto, Inc., a genome-based drug discovery and clinical-stage biotechnology company, announced on Feb. 14 that it has entered into a clinical trial agreement with University Hospitals Cleveland Medical Center in the United States to pursue an investigator-initiated clinical trial in patients with
LG Chem announced on Jan. 19 that it has received approval from the US FDA for clinical phase 1 studies (investigational new drug; IND) for ‘LC542019,’ which is a new drug candidate material for treating type 2 diabetes that can improve insulin resistance.With the approval, LG Chem has now procured